Life sciences leaders are placing serious bets on AI. A lot of those bets are being placed on data foundations that were never built for the speed, or the scrutiny AI now demands.

The uncomfortable part is that most companies don’t have a data shortage. They have a confidence problem. Data is everywhere; spread across delivery channels, vendors, contracts, systems, owners, formats, and definitions that don’t quite line up. That fragmentation doesn’t just slow teams down. It quietly undermines the intelligence leaders are counting on to grow, manage risk, and compete.

The next real advantage won’t come from acquiring more data. It will come from being able to apply trusted, governed, AI-ready data to decisions faster than the market moves.

Read the full insight brief to learn more.